David A. Santos - Feb 2, 2024 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role
EVP, Chief Commercial Officer
Signature
/s/ Raymond Furey (Attorney-in-Fact)
Stock symbol
RIGL
Transactions as of
Feb 2, 2024
Transactions value $
-$16,496
Form type
4
Date filed
2/6/2024, 08:18 PM
Previous filing
Jan 25, 2024
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RIGL Common Stock Sale -$6.33K -5.6K -1.54% $1.13 358K Feb 2, 2024 Direct F1
transaction RIGL Common Stock Sale -$10.2K -8.92K -2.49% $1.14 349K Feb 5, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.